부산대학교 도서관

Mäenpää J; Anderson I; Owen CA; Emerath U; Hughes R; Sultana SR; Olsson M

International Journal of COPD, Vol 20, Pp 723-734 (2025)

Kjeldsen MK; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU.; Bagger FO; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Roed H; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU.; Nyvang GB; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Oncology, Odense University Hospital, Odense, Denmark.; Haslund CA; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Oncology, Aalborg University Hospital, Aalborg.; Knudsen AO; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Oncology, Odense University Hospital, Odense, Denmark.; Motavaf AK; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Oncology, Aalborg University Hospital, Aalborg.; Malander S; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Oncology, Department of Clinical Science, Skåne University Hospital, Lund University, Lund, Sweden.; Anttila M; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Obstetrics and Gynecology, Kuopio University Hospital, Finland.; Lindahl G; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Oncology, Linköping University Hospital, Linköping, Sweden; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Mäenpää J; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Tampere University and Cancer Center, Tampere University Hospital, Tampere, Finland.; Dimoula M; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.; Werner T; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Iversen TZ; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Oncology, Herlev-Gentofte University Hospital, Herlev, Denmark.; Hietanen S; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Obst & Gyn, Turku University Hospital and FICAN west, Turku Finland.; Fokdal L; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Denmark.; Dahlstrand H; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Oncology-Pathology, Karolinska Institutet and Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.; Bjørge L; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Birrer M; Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, USA; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Mirza MR; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Nordic Society of Gynecological Oncology-Clinical Trial Unit, NSGO-CTU.; Rossing M; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Electronic address: caroline.maria.rossing@regionh.dk.

Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol

Clubb JHA; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Pakola SA; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Joenväärä S; Transplantation Laboratory, Faculty of Medicine, University of Helsinki, Helsinki, Finland; HUSLAB, Helsinki University Hospital, 00290 Helsinki, Finland.; Kudling TV; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Tohmola T; Transplantation Laboratory, Faculty of Medicine, University of Helsinki, Helsinki, Finland; HUSLAB, Helsinki University Hospital, 00290 Helsinki, Finland.; Arias V; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Jirovec E; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; van der Heijden M; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Quixabeira DCA; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Pasanen A; Department of Pathology, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland.; Haybout L; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Ojala N; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Basnet S; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Eleuteri A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Ferrero JD; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Hirvenoja S; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.; Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.; Mäenpää J; Docrates Cancer Center, 00180 Helsinki, Finland.; Jalkanen K; Comprehensive Cancer Center, Helsinki University Hospital, 00290 Helsinki, Finland.; Block MS; Mayo Clinic Cancer Center, Rochester, MN 55905, USA.; Alanko T; Docrates Cancer Center, 00180 Helsinki, Finland.; Monberg T; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.; Zahraoui S; TILT Biotherapeutics, 00290 Helsinki, Finland.; Grönberg-Vähä-Koskela S; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; Comprehensive Cancer Center, Helsinki University Hospital, 00290 Helsinki, Finland.; Salmelin N; IRCM, Insitute de Reserche en Cancérologie de Monpellier, INSERM U1194, University Montpellier, Institute Régional du Cancer Montpellier, Montpellier, France.; Kistler C; TILT Biotherapeutics, 00290 Helsinki, Finland.; Havunen R; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Sorsa S; TILT Biotherapeutics, 00290 Helsinki, Finland.; Manuel Dos Santos J; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Cervera-Carrascon V; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland.; Kanerva A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, 00290 Helsinki, Finland.; Hemminki O; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; Department of Urology, Helsinki University Hospital, 00290 Helsinki, Finland.; Renkonen R; Transplantation Laboratory, Faculty of Medicine, University of Helsinki, Helsinki, Finland; HUSLAB, Helsinki University Hospital, 00290 Helsinki, Finland.; Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland; TILT Biotherapeutics, 00290 Helsinki, Finland; Comprehensive Cancer Center, Helsinki University Hospital, 00290 Helsinki, Finland. Electronic address: akseli.hemminki@helsinki.fi.

Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

Jellesmark Jensen T; Clinical Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Electronic address: tina.jellesmarkJensen@astrazeneca.com.; Riff C; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Lund J; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Jevnikar Z; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Belvisi MG; Respiratory Pharmacology, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Keen C; Clinical Development, Alexion, AstraZeneca Rare Disease, Barcelona, Spain.; Mäenpää J; Chief Medical Office, Research & Development, Patient Safety Biopharma, AstraZeneca, Gothenburg, Sweden.; Mo J; Chief Medical Office, Research & Development, Patient Safety Biopharma, AstraZeneca, Gothenburg, Sweden.; Nemes S; Early Biostats & Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Forte Soto P; Parexel Early Phase Clinical Unit, London, United Kingdom.; Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Chetty R; Clinical Research, Celerion, Belfast, United Kingdom.; Singh D; Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, United Kingdom.; Dosanjh DPS; Clinical Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom; Birmingham Acute Care Research, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.; Zingmark P; Clinical Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Konstantinidis KV; Early Research & Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Hughes R; Clinical Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.

Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE

Lundahl A; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Hughes R; Research and Early Development, Respiratory and Immunology, AstraZeneca, Cambridge, UK.; Almquist J; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Close D; Research and Early Development, Respiratory and Immunology, AstraZeneca, Cambridge, UK.; Mäenpää J; Chief Medical Office, Research & Development, Patient Safety Biopharma, AstraZeneca, Gothenburg, Sweden.; Tehler U; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Jensen TJ; Early Respiratory and Immunology Clinical Development, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Nemes S; Early Biostats & Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Mercier AK; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Jevnikar Z; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Soto PF; Parexel Early Phase Clinical Unit, London, UK.; Singh D; Medicines Evaluation Unit, Manchester University NHS Foundation Hospital Trust, University of Manchester, Manchester, UK.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

Tandaric L; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.; Auranen A; Department of Obstetrics and Gynecology and Tays Cancer Centre, Tampere University Hospital, Finland.; Nordic Society of Gynaecological Oncology - Clinical Trial Unit (NSGO-CTU), Tampere, Finland.; Kleinmanns K; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; DePont Christensen R; Nordic Society of Gynaecological Oncology - Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Vestrheim Thomsen LC; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.; Department of Health Registry Research and Development, Norwegian Institute of Public Health, Oslo, Norway.; Wogsland CE; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Kinn Therapeutics AS, Bergen, Norway.; McCormack E; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Centre for Pharmacy, Department of Clinical Science, University of Bergen, Norway.; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.; Mäenpää J; Department of Obstetrics and Gynecology and Tays Cancer Centre, Tampere University Hospital, Finland.; Nordic Society of Gynaecological Oncology - Clinical Trial Unit (NSGO-CTU), Tampere, Finland.; Faculty of Medicine and Health Technology, Tampere University, Finland.; Madsen K; Nordic Society of Gynaecological Oncology - Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Stampe Petersson K; Nordic Society of Gynaecological Oncology - Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Mirza MR; Nordic Society of Gynaecological Oncology - Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark.; Bjørge L; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.

Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

Block MS; Mayo Clinic Cancer Center, Rochester, MN, USA.; Clubb JHA; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Mäenpää J; Docrates Cancer Center, Helsinki, Finland.; Tampere University, Faculty of Medicine and Medical Technology, Tampere, Finland.; Pakola S; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Quixabeira DCA; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Kudling T; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Jirovec E; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Haybout L; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; van der Heijden M; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Zahraoui S; TILT Biotherapeutics Ltd, Helsinki, Finland.; Grönberg-Vähä-Koskela S; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Raatikainen S; TILT Biotherapeutics Ltd, Helsinki, Finland.; Arias V; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Basnet S; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Ojala N; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Pellinen T; Digital Microscopy and Molecular Pathology Unit, Institute for Molecular Medicine Finland, Helsinki, Finland.; Hemmes A; Digital Microscopy and Molecular Pathology Unit, Institute for Molecular Medicine Finland, Helsinki, Finland.; Välimäki K; Digital Microscopy and Molecular Pathology Unit, Institute for Molecular Medicine Finland, Helsinki, Finland.; Pasanen A; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Alanko T; Docrates Cancer Center, Helsinki, Finland.; Adamo D; Mayo Clinic Cancer Center, Rochester, MN, USA.; Ramadan S; Docrates Cancer Center, Helsinki, Finland.; Sormunen J; Docrates Cancer Center, Helsinki, Finland.; Kononen J; Docrates Cancer Center, Helsinki, Finland.; Cohen JW; Merck & Co. Inc., Rahway, NJ, USA.; Chisamore MJ; Merck & Co. Inc., Rahway, NJ, USA.; Goldfinch J; TILT Biotherapeutics Ltd, Helsinki, Finland.; Sorsa S; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Havunen R; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Kistler C; TILT Biotherapeutics Ltd, Helsinki, Finland.; Kalervo A; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cervera-Carrascon V; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Dos Santos JM; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Hemminki A; TILT Biotherapeutics Ltd, Helsinki, Finland. akseli.hemminki@helsinki.fi.; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland. akseli.hemminki@helsinki.fi.; Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland. akseli.hemminki@helsinki.fi.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Mulugeta A; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia. anwarmulugeta.gebremichael@unisa.edu.au.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia. anwarmulugeta.gebremichael@unisa.edu.au.; Department of Pharmacology and Clinical Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. anwarmulugeta.gebremichael@unisa.edu.au.; Stacey D; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; Lumsden AL; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; Madakkatel I; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; Lee SH; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.; UniSA Allied Health & Human Performance, University of South Australia, Adelaide, SA, Australia.; Mäenpää J; Faculty of Medicine and Medical Technology, Tampere University, Tampere, Finland.; Cancer Centre, Tampere University Hospital, Tampere, Finland.; Oehler MK; Department of Gynaecological Oncology, Royal Adelaide Hospital, Adelaide, SA, Australia.; Adelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.; Hyppönen E; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Madakkatel I; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia; South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.; Lumsden AL; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia; South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.; Mulugeta A; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia; South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia; Department of Pharmacology and Clinical Pharmacy, College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia.; Mäenpää J; Faculty of Medicine and Medical Technology, Tampere University, Tampere, Finland.; Oehler MK; Department of Gynaecological Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia; Adelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia.; Hyppönen E; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia; South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia. Electronic address: Elina.Hypponen@unisa.edu.au.

Publisher: Elsevier Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

Harter P; Department of Gynaecology & Gynaecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany; Philipps University, Marburg, Germany; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Studiengruppe, Germany.; Marth C; Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-Austria), Austria.; Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France.; Cropet C; Department of Biostatistics, Centre Léon Bérard, Lyon, France.; Lorusso D; Istituto Tumori Milano + Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy; Catholic University of Sacred Heart, Milan, Italy; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Italy.; Guerra-Alía EM; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain; Grupo Español de Investigación en Cáncer de Ovario (GEICO), Spain.; Matsumoto T; Ehime University Hospital, Toon, Japan; Gynecologic Oncology Trial and Investigation Consortium (GOTIC), Japan.; Vergote I; Department of Obstetrics and Gynaecology, University Hospital Leuven, Leuven Cancer Institute, Belgium; Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium.; Colombo N; University of Milan-Bicocca, European Institute of Oncology IRCCS, Milan, Italy; Mario Negri Gynecologic Oncology Group (MANGO), Italy.; Mäenpää J; Department of Obstetrics and Gynecology and Cancer Center, Tampere University Hospital, Tampere, Finland; Nordic Society of Gynecologic Oncology (NSGO), Finland.; Lebreton C; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.; de Gregorio N; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Studiengruppe, Germany; Universitätsklinikum Ulm, Klinik für Frauenheilkunde und Geburtshilfe, Ulm, SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany.; Mosconi AM; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Italy; S.C. di Oncologia Medica Osp. S. Maria della Misericordia - AO di Perugia, Perugia, Italy.; Rubio-Pérez MJ; Grupo Español de Investigación en Cáncer de Ovario (GEICO), Spain; Medical Oncology Department, Hospital Reina Sofía, Córdoba, Spain.; Bourgeois H; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France; Medical Oncology Department, Centre Jean Bernard - Clinique Victor Hugo, Le Mans, France.; Fasching PA; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Studiengruppe, Germany; Gynecology and Obstetrics Translational Medicine, Universitätsfrauenklinik Erlangen, Erlangen, Germany.; Cecere SC; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Italy; Department of Urology and Gynecology, Istituto Nazionale Tumori 'Fondazione G Pascale', IRCCS, Naples, Italy.; Hardy-Bessard AC; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France; Oncologie Médicale, Centre CARIO - HPCA, Plérin Sur Mer, Plérin, France.; Denschlag D; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Studiengruppe, Germany; Hochtaunuskliniken, Bad Homburg, Germany.; de Percin S; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France; APHP - Hôpital Cochin, Paris, France.; Hanker L; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Studiengruppe, Germany; Universitätsklinikum Schleswig-Holstein, Klinik für Gynäkologie und Geburtshilfe, Campus Lübeck, Lübeck, Germany; Universitätsklinikum Münster, Klinik für Gynäkologie und Geburtshilfe, Münster, Germany.; Favier L; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France; Centre Georges François Leclerc, Dijon, France.; Bauerschlag D; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Studiengruppe, Germany; Universitätsklinikum Schleswig-Holstein, Klinik für Gynäkologie und Geburtshilfe, Campus Kiel, Kiel, Germany.; Desauw C; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France; Centre Hospitalier Régional Universitaire de Lille, Lille, France.; Hillemanns P; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Studiengruppe, Germany; Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe, Hannover, Germany.; Largillier R; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France; Centre Azuréen de Cancérologie, Mougins, France.; Sehouli J; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Studiengruppe, Germany; Charité - Campus-Virchow-Klinikum, Department of Gynecology with Center of Oncological Surgery Berlin, Frauenklinik, Berlin, Germany.; Grenier J; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France; Institut du cancer Avignon-Provence, Avignon, Paris.; Pujade-Lauraine E; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France; Association de Recherche Cancers Gynécologiques (ARCAGY) Research, Paris.; Ray-Coquard I; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France; Department of Medical Oncology, Centre Léon Berard, Lyon, France. Electronic address: isabelle.ray-coquard@lyon.unicancer.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Kjeldsen MK; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Jørgensen M; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Grønseth DSB; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Schønemann-Lund M; Department of Anesthesia and Intensive Care, Odense University Hospital, Odense, Denmark.; Nyvang GB; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Oncology, Odense University Hospital, Odense, Denmark.; Haslund CA; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.; Knudsen AO; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Oncology, Odense University Hospital, Odense, Denmark.; Motavaf AK; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.; Malander S; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Oncology, Skane University Hospital, Lund University, Lund, Sweden.; Department of Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.; Anttila M; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Obstetrics and Gynecology, Kuopio University Hospital, Kuopio, Finland.; Lindahl G; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Oncology, Linköping University, Linköping, Sweden.; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Mäenpää J; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Tampere University and Cancer Center, Tampere University Hospital, Tampere, Finland.; Dimoula M; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.; Werner TL; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Iversen TZ; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Oncology, Herlev-Gentofte University Hospital, Herlev, Denmark.; Hietanen S; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Obstetrics and Gynecology, Turku University Hospital and FICAN West, Turku, Finland.; Fokdal L; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Odense, Denmark.; Dahlstrand H; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Oncology-Pathology, Karolinska Institutet and Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.; Bjørge L; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.; Birrer MJ; Winthrop P. Rockefeller Cancer Institute, Little Rock, Arkansas.; Mirza MR; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Nordic Society of Gynecological Oncology-Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark.; Rossing M; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

Jirovec E; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Quixabeira DCA; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Clubb JHA; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Pakola SA; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Kudling T; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Arias V; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Haybout L; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Jalkanen K; Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.; Alanko T; Docrates Cancer Center, Helsinki, Finland.; Monberg T; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Khammari A; Department of Dermatology, Nantes University, CHU Nantes, CIC1413, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Nantes, France.; Dreno B; Nantes University, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Nantes, France.; Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Block MS; Mayo Clinic Cancer Center, Minnesota, Rochester, USA.; Adamo DA; Mayo Clinic Cancer Center, Minnesota, Rochester, USA.; Mäenpää J; Docrates Cancer Center, Helsinki, Finland.; Faculty of Medicine and Medical Technology, and Cancer Center, Tampere University and University Hospital, Tampere, Finland.; Kistler C; TILT Biotherapeutics Ltd, Helsinki, Finland.; Sorsa S; TILT Biotherapeutics Ltd, Helsinki, Finland.; Hemminki O; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Department of Urology, Helsinki University Hospital, Helsinki, Finland.; Kanerva A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Department of Gynecology and Obstetrics, Helsinki University Hospital, Helsinki, Finland.; Santos JM; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Cervera-Carrascon V; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; TILT Biotherapeutics Ltd, Helsinki, Finland.; Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland. akseli.hemminki@helsinki.fi.; TILT Biotherapeutics Ltd, Helsinki, Finland. akseli.hemminki@helsinki.fi.; Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland. akseli.hemminki@helsinki.fi.

Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

Yalew M; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia.; South Australia Health and Medical Research Institute, Adelaide, SA 5000, Australia.; Department of Public Health, College of Medicine and Health Sciences, Injibara University, Injibara P.O. Box 6040, Ethiopia.; Mulugeta A; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia.; South Australia Health and Medical Research Institute, Adelaide, SA 5000, Australia.; Department of Pharmacology and Clinical Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa P.O. Box 9086, Ethiopia.; Lumsden AL; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia.; South Australia Health and Medical Research Institute, Adelaide, SA 5000, Australia.; Madakkatel I; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia.; South Australia Health and Medical Research Institute, Adelaide, SA 5000, Australia.; Lee SH; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia.; South Australia Health and Medical Research Institute, Adelaide, SA 5000, Australia.; UniSA Allied Health & Human Performance, University of South Australia, Adelaide, SA 5001, Australia.; Oehler MK; Department of Gynecological Oncology, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.; Adelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide, SA 5006, Australia.; Mäenpää J; Faculty of Medicine and Medical Technology, Tampere University, 33014 Tampere, Finland.; Cancer Centre, Tampere University and University Hospital, 33520 Tampere, Finland.; Hyppönen E; Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia.; South Australia Health and Medical Research Institute, Adelaide, SA 5000, Australia.

Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6643 (Electronic) Linking ISSN: 20726643 NLM ISO Abbreviation: Nutrients Subsets: MEDLINE

Kuittinen, T; Rovio, P; Luukkaala, T; Laurila, M; Grenman, S; Kallioniemi, A; Mäenpää J

Anticancer Research. 40(6):3129-3138

Mirza MR; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Nordic Society of Gynaecological Oncology Clinical Trial Unit (NSGO-CTU), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: mansoor.raza.mirza@regionh.dk.; Tandaric L; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.; Henriksen JR; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Mäenpää J; Department of Obstetrics and Gynecology and Tays Cancer Centre, Tampere University Hospital and Tampere University, Finland.; Christensen RD; Research Unit of General Practice, University of Southern Denmark, Institute of Public Health, Odense, Denmark.; Waldstrøm M; Department of Pathology, Hvidovre Hospital, Hvidovre, Denmark; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.; Lindemann K; Department of Gynecological Oncology, Oslo University Hospital, Division of Cancer Medicine, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Roed H; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Auranen A; Department of Obstetrics and Gynecology and Tays Cancer Centre, Tampere University Hospital and Tampere University, Finland.; Akslen LA; Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, Section for Pathology, University of Bergen, Bergen, Norway; Department of Pathology, Haukeland University Hospital, Bergen, Norway.; Thomsen LCV; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.; Lindberg SN; Nordic Society of Gynaecological Oncology Clinical Trial Unit (NSGO-CTU), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Madsen K; Nordic Society of Gynaecological Oncology Clinical Trial Unit (NSGO-CTU), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Bjørge L; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.

Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Sadiq MW; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Asimus S; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, Sweden.; Belvisi MG; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology Group, National Heart & Lung Institute, Imperial College London, London, UK.; Brailsford W; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Fransson R; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Fuhr R; Parexel Early Phase Clinical Unit, Berlin, Germany.; Hagberg A; Patient Safety, Respiratory & Immunology, Chief Medical Office, R&D, AstraZeneca, Gothenburg, Sweden.; Hashemi M; Early Biostats & Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Jellesmark Jensen T; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Jonsson J; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Keen C; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Körnicke T; Parexel Early Phase Clinical Unit, Berlin, Germany.; Kristensson C; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Mäenpää J; Patient Safety, Respiratory & Immunology, Chief Medical Office, R&D, AstraZeneca, Gothenburg, Sweden.; Necander S; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Nemes S; Early Biostats & Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Betts J; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

Boidot R; Unit of Molecular Biology, Department of Biology and Pathology of Tumors, Georges-François Leclerc Cancer Center - UNICANCER, Dijon, France.; Blum MGB; SeqOne Genomics, Montpellier, France. Electronic address: michael.blum@seqone.com.; Wissler MP; CYPATH, Villeurbanne, France.; Gottin C; SeqOne Genomics, Montpellier, France.; Ruzicka J; SeqOne Genomics, Montpellier, France.; Chevrier S; Unit of Molecular Biology, Department of Biology and Pathology of Tumors, Georges-François Leclerc Cancer Center - UNICANCER, Dijon, France.; Delhomme TM; SeqOne Genomics, Montpellier, France.; Audoux J; SeqOne Genomics, Montpellier, France.; Jeanniard A; Agilent Technologies France, Les Ulis, France.; Just PA; APHM (Assistance Publique - Hôpitaux de Marseille), Service de Pathologie Hôpitaux et services de santé, Marseille, Provence-Alpes-Côte d'Azur, France.; Harter P; Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.; Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples, Italy.; González-Martin A; Clinica Universidad de Navarra,GEICO, Madrid, Spain.; Marth C; Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria.; Mäenpää J; Tampere University Hospital, Department of Obstetrics and Gynecology, Finland.; Colombo N; University of Milan-Bicocca and European Institute of Oncology IRCCS, Milan, Italy.; Vergote I; University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium, European Union.; Fujiwara K; Saitama Medical University International Medical Center, Saitama, Japan.; Duforet-Frebourg N; SeqOne Genomics, Montpellier, France.; Bertrand D; SeqOne Genomics, Montpellier, France.; Philippe N; SeqOne Genomics, Montpellier, France.; Ray-Coquard I; Centre Léon BERARD, and University Claude Bernard Lyon I, Lyon and Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Lyon, France.; Pujade-Lauraine E; Association de Recherche Cancers Gynécologiques (ARCAGY-GINECO), Paris, France.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Pothuri B; GOG Foundation and Departments of Obstetrics/Gynecology and Medicine, Division of Gynecologic Oncology, Laura & Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA. Electronic address: Bhavana.pothuri@nyulangone.org.; Han S; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.; Chase DM; Department of Obstetrics and Gynecology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA.; Heitz F; AGO Study Group, Department for Gynaecology and Gynaecologic Oncology, Kliniken Essen- Mitte, Essen, Germany; Department of Gynaecology, Charité-Universitätsmedizin Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; and Berlin Institute of Health, Berlin, Germany.; Burger RA; Department of Obstetrics & Gynecology, University of Pennsylvania, Philadelphia, PA, USA.; Gaba L; Medical Oncology Department, Hospital Clinic de Barcelona, Translational Genomics and Targeted Therapies in Solid Tumors, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Van Le L; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Guerra E; Medical Oncology Department, Breast and Gynaecological Cancer Unit, Hospital Ramón y Cajal, Madrid, Spain.; Bender D; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, USA.; Korach J; Gynecologic Oncology Department, The Chaim Sheba Medical Center, Sackler Medical School, Tel Aviv University, Ramat Gan, Israel.; Cloven N; Texas Oncology, Fort Worth, TX, USA.; Churruca C; Medical Oncology Department, Hospital Universitario Donostia, San Sebastian, Spain.; Follana P; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Département D'oncologie Médicale, Centre Antoine Lacassagne, Nice, France.; DiSilvestro P; Department of Obstetrics and Gynecology, Women and Infants Hospital/Alpert School of Medicine at Brown University, Providence, RI, USA.; Baurain JF; Medical Oncology Departement, Université Catholique de Louvain and Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Jardon K; Department of Obstetrics and Gynecology, McGill University, Montreal, QC, Canada.; Pisano C; Department of Urology and Gynaecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.; Peen U; Herlev University Hospital, Herlev, Denmark.; Mäenpää J; NSGO and Tampere University, Tampere, Finland.; Gupta D; GSK, Waltham, MA, USA.; Bacqué E; GSK, Waltham, MA, USA.; Li Y; GSK, Waltham, MA, USA.; Compton N; GSK, London, United Kingdom.; Antonova J; GSK, Waltham, MA, USA.; Monk BJ; HonorHealth Research Institute, University of Arizona College of Medicine, Phoenix, and Creighton University School of Medicine, Phoenix, AZ, USA.; González-Martín A; Medical Oncology Department and Program in Solid Tumours - CIMA, Cancer Center Clínica Universidad de Navarra, Grupo Español de Investigación en Cáncer de Ovario (GEICO), Madrid, Spain.

Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Kalamo M; Department of Gynecology and Obstetrics, Tampere University Hospital, Tampere, Finland. mari.h.kalamo@pshp.fi.; Mäenpää J; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Tampere University Hospital Cancer Center, Tampere University Hospital, Tampere, Finland.; Seppälä T; Department of Gastrointestinal Surgery, Helsinki University Hospital, Helsinki, Finland.; Mecklin JP; Department of Surgery, Central Finland Central Hospital, Jyväskylä, Finland.; Faculty of Sports and Health Sciences, University of Jyväskylä, Jyväskylä, Finland.; Pylvänäinen K; Department of Education and Science, Central Finland Health Care District, Jyväskylä, Finland.; Staff S; Department of Gynecology and Obstetrics, Tampere University Hospital, Tampere, Finland.; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Tampere University Hospital Cancer Center, Tampere University Hospital, Tampere, Finland.

Publisher: BioMed Central Country of Publication: Poland NLM ID: 101231179 Publication Model: Electronic Cited Medium: Print ISSN: 1731-2302 (Print) Linking ISSN: 17312302 NLM ISO Abbreviation: Hered Cancer Clin Pract Subsets: PubMed not MEDLINE

Callens C; Genetics Department, Institut Curie and Paris Sciences Lettres University, Paris, France.; Vaur D; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.; Soubeyran I; Biopathology Department, Institut Bergonié, Bordeaux, France.; Rouleau E; Biopathology Department, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Just PA; Department of Pathological Anatomy and Cytology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France, Genetics Department, Hôpital Universitaire Pitié-Salpétrière, Assistance Publique - Hôpitaux de Paris, Paris, France.; Guillerm E; Department of Pathological Anatomy and Cytology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France, Genetics Department, Hôpital Universitaire Pitié-Salpétrière, Assistance Publique - Hôpitaux de Paris, Paris, France.; Golmard L; Genetics Department, Institut Curie and Paris Sciences Lettres University, Paris, France.; Goardon N; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.; Sevenet N; Biopathology Department, Institut Bergonié, Bordeaux, France.; Cabaret O; Biopathology Department, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Harter P; Obstetric and Gynecologic Department, Kliniken Essen Mitte, Essen, AGO De, Germany.; Gonzalez-Martin A; Oncology Department, Clínica Universidad de Navarra, Madrid, formerly MD Anderson Cancer Center, Madrid, GEICO, Spain.; Fujiwara K; Gynecologic Oncologic Department, Saitama Medical University, Saitama, GOTIC, Japan.; Cecere SC; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Mito Italy.; Colombo N; Gynecology Oncology Division, European Institute of Oncology, Milan, Mango Italy.; Marth C; Obstetric and Gynecologic Department, Medical University of Innsbruck, AGO Au, Austria.; Vergote I; Gynecologic Oncologic Department, University Hospital Leuven, Department of Gynecologic oncology, Leuven Cancer Institute, Leuven, BGOG, Belgium.; Maenpaa J; Gynecologic Oncologic Department, Tampere University and University Hospital Cancer Centre, Tampere, NSGO, Finland.; Pujade-Lauraine E; ARCAGY Research, Paris, France.; Ray-Coquard I; Medical Oncology Department, Centre Léon Bérard and University, Claude Bernard Lyon 1, Lyon, GINECO, France.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE